Oncology
0 drugs are in development for Neurofibromatosis 1.
- Companies
- 0
- Clinical trials
- 10
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Neurofibromatosis 1 pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
About this indication
Neurofibromatosis 1 context
Oncology·MeSH: Neurofibromatosis 1 (D009456)
Also known as: Molluscum Fibrosum, NF1 (Neurofibromatosis 1), Neurofibromatoses, Peripheral, Neurofibromatoses, Type I, Neurofibromatosis I, Neurofibromatosis, Peripheral, Neurofibromatosis, Peripheral Type, Neurofibromatosis, Peripheral, NF 1, Neurofibromatosis, Peripheral, NF1, Neurofibromatosis, Type I, Recklinghausen Disease of Nerve, Recklinghausen Disease, Nerve, Recklinghausens Disease of Nerve, Type 1 Neurofibromatosis, Type 1, Neurofibromatosis, Type I, Neurofibromatosis, von Recklinghausen Disease, von Recklinghausens Disease